diltiazem has been researched along with deacetyldiltiazem in 57 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 18 (31.58) | 18.7374 |
1990's | 19 (33.33) | 18.2507 |
2000's | 16 (28.07) | 29.6817 |
2010's | 4 (7.02) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Finegan, BA; Hussain, MD; Tam, YK | 1 |
Lee, MH; Lee, YH; Shim, CK | 1 |
Bai, SA; Lankford, S; Maskasame, C | 1 |
Chiap, P; Crommen, J; Hubert, P | 2 |
Dimmitt, DC; Elvin, AT; Giesing, DH; Lanman, RC; Yu, DK | 1 |
Derendorf, H; Lefevre, JF; Lopez, LM; Schaefer, HG; Ververs, FF | 1 |
Ito, K; Kurosawa, N; Kurosawa, S; Owada, E; Soeda, H | 1 |
Boucher, S; Caillé, G; Du Souich, P; Lery, L; Lery, N; Pilon, D; Spenard, J; Varin, F; Vezina, M | 1 |
Chow, MS; Zhao, H | 1 |
Boyd, RA; Chin, SK; Don-Pedro, O; Giacomini, KM; Sheiner, LB; Verotta, D; Williams, RL | 1 |
Höglund, P; Nilsson, LG | 4 |
Kawakita, S; Kinoshita, M; Morita, K; Muranishi, S; Nishikawa, S; Ono, T; Shibata, N; Shimakawa, H; Takada, K | 1 |
Bhamra, RK; Holt, DW; Ward, AE | 1 |
Abernethy, DR; Mitchell, JR; Montamat, SC | 1 |
Abernethy, DR; Montamat, SC | 1 |
Grech-Belanger, O; Langlois, S; Leboeuf, E | 1 |
Downing, SJ; Edwards, D; Hollingsworth, M | 1 |
Bjornsson, TD; Ellenbogen, KA; McCarthy, EA; Pritchett, EL; Roark, SF; Smith, MS | 1 |
Kelly, JG; Kinney, CD | 1 |
Abernethy, DR; Schwartz, JB; Todd, EL | 1 |
Besner, JG; Biron, P; Caillé, G; Clozel, JP; Taeymans, Y; Théroux, P | 1 |
Dimmitt, DC; Lacz, JP; Runser, DJ; Wiens, RE | 1 |
Pritchett, EL; Shand, DG; Smith, MS; Verghese, CP | 1 |
Caillé, G; du Souich, P; Homsy, W; Lefebvre, M | 1 |
Abadi, AH; Lopez, LM; Rutledge, DR | 1 |
Abadi, AH; Beaudreau, CA; Lopez, LM; Rutledge, DR | 1 |
Frishman, WH | 1 |
Hutt, V; Jaeger, H; Janik, F; Kappler, J; Maccari, M; Pabst, G; Ravelli, V | 1 |
Coors, C; Schulz, HG; Stache, F | 1 |
Caillé, G; du Souich, P; Homsy, W | 1 |
Dunham, GD; Williamson, KM | 1 |
Koves, EM; Lawrence, K; Mayer, JM | 1 |
Buckley, SJ; Feng, JD; Yeung, PK | 1 |
Christensen, H; Molden, E; Sund, RB | 1 |
Aramayona, JJ; Bregante, MA; Fraile, LJ; Garcia, MA; Solans, C | 1 |
Bregante, MA; Fraile, LJ; Garcia, MA; Solans, C | 1 |
Burm, JP; Choi, JS; Lee, JH | 1 |
Blaschke, G; Chankvetadze, B; Kartozia, I | 1 |
Asberg, A; Christensen, H; Molden, E | 1 |
Choi, JS; Kim, YG | 1 |
Bergan, S; Bøe, GH; Christensen, H; Johansen, PW; Lehne, G; Molden, E; Reubsaet, L; Rootwelt, H; Rugstad, HE | 1 |
Albert, KS; Eradiri, O; Lai, JC; Sista, S | 1 |
Burm, JP; Choi, JS | 1 |
Choi, HJ; Choi, JS | 1 |
Choi, JS; Han, HK | 1 |
Chang, KS; Choi, DH; Choi, JS; Hong, SP | 1 |
Choi, DH; Choi, JS; Hong, SP | 1 |
Choi, JS; Li, C | 1 |
Cho, YA; Choi, DH; Choi, JS | 1 |
Bertrand, N; Bouvet, C; Leroux, JC; Moreau, P | 1 |
Chang, KS; Choi, DH; Chung, JW; Ha, SI; Han, JY; Hong, SP; Koh, YY; Yang, JS | 1 |
Choi, DH; Choi, JS; Li, C | 1 |
Han, HK; Kang, KW; Qiang, F | 1 |
5 trial(s) available for diltiazem and deacetyldiltiazem
Article | Year |
---|---|
Pharmacokinetics of diltiazem and propranolol when administered alone and in combination.
Topics: Adult; Diltiazem; Drug Therapy, Combination; Humans; Male; Propranolol; Tablets | 1991 |
Influence of food on the bioavailability of diltiazem and two of its metabolites following the administration of conventional tablets and slow-release capsules.
Topics: Administration, Oral; Adolescent; Adult; Biological Availability; Delayed-Action Preparations; Diltiazem; Drug Administration Schedule; Food; Humans; Male; Middle Aged | 1990 |
A new extended-release formulation of diltiazem HCl for the treatment of mild-to-moderate hypertension.
Topics: Blood Pressure; Capsules; Clinical Trials as Topic; Delayed-Action Preparations; Diltiazem; Dose-Response Relationship, Drug; Double-Blind Method; Female; Food; Humans; Hypertension; Male; Middle Aged; Retrospective Studies | 1993 |
Evaluation of pharmacokinetics, bioavailability and dose linearity of diltiazem in healthy volunteers.
Topics: Adolescent; Adult; Biological Availability; Chromatography, High Pressure Liquid; Diltiazem; Humans; Male; Middle Aged; Spectrophotometry, Ultraviolet | 1993 |
Pharmacokinetics of a novel diltiazem HCl extended-release tablet formulation for evening administration.
Topics: Adult; Biological Availability; Chronotherapy; Circadian Rhythm; Cross-Over Studies; Delayed-Action Preparations; Diltiazem; Doxepin; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Pharmacokinetics; Tablets | 2003 |
52 other study(ies) available for diltiazem and deacetyldiltiazem
Article | Year |
---|---|
Pharmacokinetics of diltiazem in patients undergoing coronary artery bypass grafting.
Topics: Administration, Oral; Aged; Coronary Artery Bypass; Diltiazem; Female; Humans; Male; Middle Aged; Preoperative Care | 1992 |
Decreased systemic clearance of diltiazem with increased hepatic metabolism in rats with uranyl nitrate-induced acute renal failure.
Topics: Acute Kidney Injury; Animals; Biological Availability; Blood Proteins; Chromatography, High Pressure Liquid; Diltiazem; Injections, Intravenous; Liver; Liver Circulation; Male; Portal Vein; Protein Binding; Rats; Rats, Wistar; Uranyl Nitrate | 1992 |
The effects of chronic oral diltiazem and cimetidine dosing on the pharmacokinetics and negative dromotropic action of intravenous and oral diltiazem in the dog.
Topics: Administration, Oral; Animals; Blood Proteins; Cimetidine; Depression, Chemical; Diltiazem; Dogs; Drug Administration Schedule; Drug Interactions; Female; Infusions, Intravenous; Neural Conduction; Protein Binding | 1992 |
Automatic determination of diltiazem and desacetyldiltiazem in human plasma using liquid-solid extraction on disposable cartridges coupled to HPLC--Part I: Optimization of the HPLC system and method validation.
Topics: Automation; Chromatography, High Pressure Liquid; Diltiazem; Humans; Molecular Structure; Reproducibility of Results; Sensitivity and Specificity | 1991 |
Automatic determination of diltiazem and desacetyldiltiazem in human plasma using liquid-solid extraction on disposable cartridges coupled to HPLC--Part II: Optimization of liquid-solid extraction.
Topics: Automation; Chromatography, High Pressure Liquid; Diltiazem; Humans; Hydrogen-Ion Concentration; Reference Standards; Solutions; Water | 1991 |
Simultaneous assay of propranolol, diltiazem and metabolites of diltiazem in human plasma by liquid chromatography.
Topics: Biotransformation; Chromatography, High Pressure Liquid; Diltiazem; Humans; Male; Propranolol; Spectrophotometry, Ultraviolet | 1990 |
Pharmacokinetics of diltiazem in patients with liver cirrhosis.
Topics: Adult; Aged; Biotransformation; Chromatography, High Pressure Liquid; Creatinine; Delayed-Action Preparations; Diltiazem; Female; Half-Life; Humans; Liver Cirrhosis; Male; Middle Aged; Regression Analysis | 1990 |
Analysis of diltiazem and desacetyldiltiazem in plasma using modified high-performance liquid chromatography: improved sensitivity and reproducibility.
Topics: Cardiovascular Agents; Chromatography, High Pressure Liquid; Diltiazem; Humans; Spectrophotometry, Ultraviolet | 1989 |
The pharmacokinetics and pharmacodynamics of diltiazem and its metabolites in healthy adults after a single oral dose.
Topics: Administration, Oral; Adult; Chromatography, High Pressure Liquid; Diltiazem; Half-Life; Humans; Male; Protein Binding | 1989 |
Pharmacokinetics of diltiazem and its metabolites after repeated multiple-dose treatments in healthy volunteers.
Topics: Adult; Biotransformation; Blood Chemical Analysis; Diltiazem; Feces; Female; Half-Life; Humans; Middle Aged; Reference Values | 1989 |
Pharmacokinetics of diltiazem and its metabolites after repeated single dosing in healthy volunteers.
Topics: Adult; Chromatography, High Pressure Liquid; Diltiazem; Female; Half-Life; Humans; Male; Middle Aged | 1989 |
Pharmacokinetics of diltiazem and its metabolites after single and multiple dosing in healthy volunteers.
Topics: Administration, Oral; Adult; Biotransformation; Capsules; Diltiazem; Feces; Female; Half-Life; Humans; Male; Middle Aged; Reference Values | 1989 |
Physiological disposition of intravenously administered 14C-labeled diltiazem in healthy volunteers.
Topics: Adult; Blood Pressure; Diltiazem; Electrocardiography; Female; Half-Life; Heart Rate; Humans; Infusions, Intravenous; Male; Middle Aged; Scintillation Counting | 1988 |
Effects of diltiazem on rheological properties of human blood.
Topics: Adenosine Triphosphate; Blood Platelets; Blood Viscosity; Diltiazem; Erythrocyte Deformability; Erythrocytes; Humans; In Vitro Techniques; Injections, Intravenous; Middle Aged; Osmotic Fragility; Pentoxifylline | 1988 |
HPLC measurement of diltiazem and desacetyldiltiazem in serum or plasma.
Topics: Animals; Cattle; Chromatography, High Pressure Liquid; Diltiazem; Humans | 1987 |
High-performance liquid chromatographic determination of diltiazem and its major metabolites, N-monodemethyldiltiazem and desacetyldiltiazem, in plasma.
Topics: Aged; Biotransformation; Chromatography, High Pressure Liquid; Diltiazem; Humans; Hypertension; Kinetics; Male; Spectrophotometry, Ultraviolet | 1987 |
N-monodesmethyldiltiazem is the predominant metabolite of diltiazem in the plasma of young and elderly hypertensives.
Topics: Adult; Aged; Aged, 80 and over; Aging; Biotransformation; Diltiazem; Female; Half-Life; Humans; Hypertension; Kinetics; Male | 1987 |
Assay of diltiazem and deacetyldiltiazem by capillary gas chromatography.
Topics: Biotransformation; Chromatography, Gas; Diltiazem; Drug Stability; Humans; Hydrogen-Ion Concentration; Kidney Failure, Chronic; Kinetics | 1987 |
Diltiazem pharmacokinetics in the rat and relationship between its serum concentration and uterine and cardiovascular effects.
Topics: Animals; Chromatography, High Pressure Liquid; Diltiazem; Dose-Response Relationship, Drug; Female; Hemodynamics; Infusions, Intravenous; Injections, Intravenous; Ovariectomy; Pregnancy; Rats; Uterine Contraction | 1987 |
Effects of sustained intravenous diltiazem infusion in healthy persons.
Topics: Adult; Atrioventricular Node; Blood Pressure; Diltiazem; Electrocardiography; Humans; Infusions, Intravenous; Kinetics; Male | 1986 |
Estimation of concentrations of diltiazem in plasma using normal-phase column liquid chromatography with ultraviolet detection.
Topics: Chromatography, Liquid; Diltiazem; Humans; Spectrophotometry, Ultraviolet | 1986 |
Diltiazem and desacetyldiltiazem analysis in human plasma using high-performance liquid chromatography: improved sensitivity without derivation.
Topics: Adult; Benzazepines; Chromatography, High Pressure Liquid; Desipramine; Diltiazem; Female; Half-Life; Humans; Kinetics | 1985 |
Improved gas chromatographic determination of diltiazem and deacetyldiltiazem in human plasma.
Topics: Benzazepines; Biological Availability; Chromatography, Gas; Diltiazem; Humans; Kinetics | 1984 |
Quantitation of diltiazem and desacetyldiltiazem in dog plasma by high-performance liquid chromatography.
Topics: Animals; Benzazepines; Calcium Channel Blockers; Chromatography, High Pressure Liquid; Diltiazem; Dogs; Drug Stability; Hydrogen-Ion Concentration; Kinetics | 1984 |
Pharmacokinetic and pharmacodynamic effects of diltiazem.
Topics: Administration, Oral; Adult; Benzazepines; Diltiazem; Dose-Response Relationship, Drug; Female; Half-Life; Humans; Infusions, Parenteral; Kinetics; Male; Middle Aged; Myocardial Contraction | 1983 |
Metabolism of diltiazem in hepatic and extrahepatic tissues of rabbits: in vitro studies.
Topics: Animals; Diltiazem; In Vitro Techniques; Intestinal Mucosa; Kidney; Liver; Male; Rabbits | 1995 |
Liquid chromatographic determination of celiprolol, diltiazem, desmethyldiltiazem and deacetyldiltiazem in plasma using a short alkyl chain silanol deactivated column.
Topics: Celiprolol; Chromatography, High Pressure Liquid; Diltiazem; Humans; Reference Standards; Reproducibility of Results; Silanes | 1994 |
High-performance liquid chromatographic determination of diltiazem and two of its metabolites in plasma using a short alkyl chain silanol deactivated column.
Topics: Chromatography, High Pressure Liquid; Diltiazem; Humans; Hypertension; Indicators and Reagents; Male; Silanes; Spectrophotometry, Ultraviolet | 1993 |
Development and validation of a bioanalytical method for the quantification of diltiazem and desacetyldiltiazem in plasma by capillary zone electrophoresis.
Topics: Calcium Channel Blockers; Diltiazem; Electrophoresis, Capillary; Humans; Reference Standards; Reproducibility of Results; Verapamil | 1995 |
The site of absorption in the small intestine determines diltiazem bioavailability in the rabbit.
Topics: Animals; Biological Availability; Biotransformation; Blood Gas Analysis; Calcium Channel Blockers; Diltiazem; Half-Life; Hydrogen-Ion Concentration; Intestinal Absorption; Intestine, Small; Male; Rabbits | 1995 |
Plasma concentrations of diltiazem and desacetyldiltiazem in an overdose situation.
Topics: Adolescent; Antidotes; Biotransformation; Calcium Channel Blockers; Charcoal; Diltiazem; Female; Humans; Suicide, Attempted | 1996 |
Stability of diltiazem in whole blood: forensic implications.
Topics: Adult; Cardiovascular Agents; Chromatography, High Pressure Liquid; Diltiazem; Drug Stability; Fatal Outcome; Female; Forensic Medicine; Humans; Male; Middle Aged; Postmortem Changes; Reproducibility of Results; Suicide; Temperature; Time Factors | 1998 |
Pharmacokinetics and hypotensive effect of diltiazem in rabbits: comparison of diltiazem with its major metabolites.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Chromatography, High Pressure Liquid; Diltiazem; Dose-Response Relationship, Drug; Female; Hypertension; Injections, Intravenous; Molecular Structure; Rabbits | 1998 |
Extensive metabolism of diltiazem and P-glycoprotein-mediated efflux of desacetyl-diltiazem (M1) by rat jejunum in vitro.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; Biological Availability; Biological Transport; Biotransformation; Calcium Channel Blockers; Dealkylation; Diltiazem; Hydrolysis; In Vitro Techniques; Intestinal Absorption; Jejunum; Male; Rats; Rats, Wistar | 2000 |
Diltiazem blood pharmacokinetics in the pregnant and non-pregnant rabbit: maternal and foetal tissue levels.
Topics: Animals; Antihypertensive Agents; Brain; Diltiazem; Female; Fetal Blood; Fetus; Injections, Intravenous; Kidney; Kinetics; Maternal-Fetal Exchange; Muscles; Placenta; Pregnancy; Pregnancy, Animal; Regression Analysis; Tissue Distribution; Uterus | 2000 |
Altered diltiazem metabolism in the neonatal rabbit following intra-uterine chronic exposure to diltiazem.
Topics: Age Factors; Animals; Animals, Newborn; Body Weight; Brain; Chromatography, High Pressure Liquid; Diltiazem; Female; Intestinal Mucosa; Liver; Lung; Maternal Exposure; Pregnancy; Rabbits; Time Factors; Tissue Distribution | 2001 |
Pharmacokinetics of diltiazem and its major metabolite, deacetyidiltiazem after oral administration of diltiazem in mild and medium folate-induced renal failure rabbits.
Topics: Acute Kidney Injury; Animals; Area Under Curve; Calcium Channel Blockers; Chromatography, High Pressure Liquid; Diltiazem; Folic Acid; Male; Rabbits | 2001 |
Simultaneous enantioseparation of cis-diltiazem hydrochloride and its metabolite cis-desacetyldiltiazem using high-performance liquid chromatography and capillary electrophoresis.
Topics: Calcium Channel Blockers; Chromatography, High Pressure Liquid; Diltiazem; Electrophoresis, Capillary; Mass Spectrometry; Molecular Structure; Stereoisomerism | 2002 |
Desacetyl-diltiazem displays severalfold higher affinity to CYP2D6 compared with CYP3A4.
Topics: Calcium Channel Blockers; Cells, Cultured; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Diltiazem; Hepatocytes; Humans; Mixed Function Oxygenases | 2002 |
Pharmacokinetic changes of diltiazem and desacetyldiltiazem after oral administration of diltiazem in rabbits with diabetes mellitus induced by alloxan.
Topics: Administration, Oral; Alloxan; Animals; Area Under Curve; Diabetes Mellitus, Experimental; Diltiazem; Male; Rats | 2002 |
Pharmacokinetics of diltiazem and its metabolites in relation to CYP2D6 genotype.
Topics: Area Under Curve; Calcium Channel Blockers; Cytochrome P-450 CYP2D6; Diltiazem; Female; Genotype; Humans; Male | 2002 |
The influence of cimetidine on the pharmacokinetics of diltiazem and its main metabolite in rabbits.
Topics: Algorithms; Animals; Anti-Ulcer Agents; Area Under Curve; Biotransformation; Calcium Channel Blockers; Cimetidine; Diltiazem; Drug Interactions; Half-Life; Male; Rabbits | 2004 |
Effects of morin pretreatment on the pharmacokinetics of diltiazem and its major metabolite, desacetyldiltiazem in rats.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Calcium Channel Blockers; Cytochrome P-450 Enzyme Inhibitors; Dietary Supplements; Diltiazem; Drug Interactions; Flavonoids; Intestinal Absorption; Male; Models, Animal; Rats; Rats, Sprague-Dawley | 2005 |
Enhanced oral exposure of diltiazem by the concomitant use of naringin in rats.
Topics: Animals; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Calcium Channel Blockers; Cytochrome P-450 Enzyme Inhibitors; Diltiazem; Drug Interactions; Flavanones; Male; Rats; Rats, Sprague-Dawley | 2005 |
Effect of atorvastatin on the pharmacokinetics of diltiazem and its main metabolite, desacetyldiltiazem, in rats.
Topics: Administration, Oral; Animals; Area Under Curve; Atorvastatin; Biological Availability; Biotransformation; Calcium Channel Blockers; Diltiazem; Dose-Response Relationship, Drug; Drug Interactions; Half-Life; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Injections, Intravenous; Male; Metabolic Clearance Rate; Pyrroles; Rats; Rats, Sprague-Dawley | 2007 |
Effects of resveratrol on the pharmacokinetics of diltiazem and its major metabolite, desacetyldiltiazem, in rats.
Topics: Administration, Oral; Analysis of Variance; Animals; Antioxidants; Area Under Curve; Biological Availability; Calcium Channel Blockers; Chromatography, High Pressure Liquid; Diltiazem; Dose-Response Relationship, Drug; Drug Interactions; Injections, Intravenous; Male; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes | 2008 |
Effects of epigallocatechin gallate on the bioavailability and pharmacokinetics of diltiazem in rats.
Topics: Administration, Oral; Animals; Biological Availability; Calcium Channel Blockers; Catechin; Chromatography, High Pressure Liquid; Diltiazem; Half-Life; Injections, Intravenous; Male; Rats; Rats, Sprague-Dawley | 2008 |
Effect of hesperidin on the oral pharmacokinetics of diltiazem and its main metabolite, desacetyldiltiazem, in rats.
Topics: Administration, Oral; Animals; Antioxidants; Area Under Curve; Biological Availability; Calcium Channel Blockers; Chromatography, High Pressure Liquid; Diltiazem; Dose-Response Relationship, Drug; Drug Interactions; Hesperidin; Male; Rats; Rats, Sprague-Dawley | 2009 |
Transmembrane pH-gradient liposomes to treat cardiovascular drug intoxication.
Topics: Animals; Calcium Channel Blockers; Cell Membrane; Chemistry, Pharmaceutical; Diltiazem; Hydrogen-Ion Concentration; Hypotension; Liposomes; Male; Polyethylene Glycols; Rats; Rats, Sprague-Dawley | 2010 |
Effects of lovastatin on the pharmacokinetics of diltiazem and its main metabolite, desacetyldiltiazem, in rats: possible role of cytochrome P450 3A4 and P-glycoprotein inhibition by lovastatin.
Topics: Administration, Oral; Animals; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Calcium Channel Blockers; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Diltiazem; Dose-Response Relationship, Drug; Drug Interactions; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Male; Rats; Rats, Sprague-Dawley | 2011 |
Effects of simvastatin on the pharmacokinetics of diltiazem and its main metabolite, desacetyldiltiazem, after oral and intravenous administration in rats: possible role of P-glycoprotein and CYP3A4 inhibition by simvastatin.
Topics: Administration, Oral; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Diltiazem; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Infusions, Intravenous; Male; Rats; Rats, Sprague-Dawley; Simvastatin | 2011 |
Repeated dosing of piperine induced gene expression of P-glycoprotein via stimulated pregnane-X-receptor activity and altered pharmacokinetics of diltiazem in rats.
Topics: Alkaloids; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzodioxoles; Biological Availability; Calcium Channel Blockers; Diltiazem; Food-Drug Interactions; Gene Expression; Hep G2 Cells; Humans; Male; Piperidines; Polyunsaturated Alkamides; Pregnane X Receptor; Rats; Rats, Sprague-Dawley; Receptors, Steroid | 2012 |